Recently, LCN2 has emerged as a potential diagnostic marker for dementia,63 based on the observation of elevated LCN2 in the plasma of patients with dementia64 and in the cerebrospinal fluid (CSF) of patients with VD.65 This evidence concerns the gene LCN2 and sexually transmitted disease.